Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707694 · ClinicalTrials.gov registry record
The Longevity Genes in Founder Populations Project
A clinical trial of Extreme Longevity, sponsored by Albert Einstein College of Medicine.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 2
- Study locations
NCT00707694: Recruiting study of Extreme Longevity, sponsored by Albert Einstein College of Medicine.
NCT00707694 is a study of Extreme Longevity that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 2,000 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00707694, a study of Extreme Longevity, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
Conditions Studied
Study Locations (2)
New York
- Private Homes - New York
- Hebrew Home Riverdale - Riverdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 1998-07 |
| Est. Completion | 2032-12 |
What NCT00707694 shows while recruiting
NCT00707694 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Extreme Longevity appearing as the primary indexed condition, and to 0 interventions.
NCT00707694 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00707694 about?
NCT00707694 is a clinical study titled "The Longevity Genes in Founder Populations Project". We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replic...
What is the current status of trial NCT00707694?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 1998-07. Estimated completion is 2032-12.
What conditions does trial NCT00707694 study?
This clinical trial studies the following conditions: Extreme Longevity.
Who is sponsoring clinical trial NCT00707694?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00707694 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia